FDA approves Non-GMO BESTEVIA Reb E for use in food

BESTEVIA e+ shows great success in reducing sugar and artificial sweeteners in many applications, such as beverage, dairy, sports nutrition, condiments and bakeries

SweeGen, Inc., a US based stevia-based sweetener company, announced that the U.S. Food and Drug Administration (FDA) issued a GRAS (Generally Recognized As Safe) No Objection Letter for BESTEVIA® Rebaudioside E (“Reb E”) stevia leaf sweetener for use in foods.

“Reb E is one of the main components in our BESTEVIA e+. It was specifically created for alcoholic and non-alcoholic beverages in response to concerns from some regarding application IP for Reb M in beverages,” says Shari Joslin, VP of Application Technology, “BESTEVIA e+ provides a mouthfeel and taste closest to sugar,” she adds.

BESTEVIA e+ shows great success in reducing sugar and artificial sweeteners in many applications, such as beverage, dairy, sports nutrition, condiments and bakeries. “BESTEVIA e+ provides a clean, sugar-like taste at a price equivalent to sugar. In addition to the success we have with our non-GMO BESTEVIA Reb M and Reb D, we are excited to add BESTEVIA e+ to our sweetener portfolio,” says Katharina Pueller, director natural sweetener business. 

BESTEVIA Reb E, SweeGen’s non-caloric, high-purity stevia sweetener, is produced from the stevia leaf through a non-GMO bioconversion process. The FDA acknowledged in a letter dated June 21, 2019 that it evaluated the application and has no further questions regarding the conclusion that Reb E is GRAS under its intended use in foods.

Reb E was commercialized at the end of 2018 and is available in large quantities. Having now received the No Objection Letter from the FDA, SweeGen will continue to pursue global approvals.